WATSON 460 Pill - white round, 8mm

Pill with imprint WATSON 460 is White, Round and has been identified as Glipizide 5 mg. It is supplied by Watson Laboratories, Inc.

Glipizide is used in the treatment of Type 2 Diabetes and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 460

Glipizide

Imprint: WATSON 460
Strength: 5 mg
Color: White
Size: 8.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Sulfonylureas
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Watson Laboratories, Inc.
Inactive Ingredients: silicon dioxide, croscarmellose sodium, lactose anhydrous, microcrystalline cellulose, corn starch, stearic acid
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00591-0460	Watson Pharmaceuticals, Inc.
53002-0446	Pharmedix (repackager)
54569-3841 (Discontinued)	A-S Medication Solutions, LLC (repackager)
55289-0806	PDRX Pharmaceuticals Inc. (repackager)
63874-0316 (Discontinued)	Altura Pharmaceuticals Inc. (repackager)